From: Novel tetrahydroisoquinolines as DHFR and CDK2 inhibitors: synthesis, characterization, anticancer activity and antioxidant properties
Code
Toxicity on WI38 IC50 µM ± SD
Selectivity index (SI)
7e
19.734 ± 0.79
127.29
8d
23.301 ± 0.93
45.24
Doxorubicin
11.433 ± 0.37
52.4